Viewing Study NCT02404558


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2025-12-31 @ 3:20 PM
Study NCT ID: NCT02404558
Status: COMPLETED
Last Update Posted: 2016-03-28
First Post: 2015-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module